Sporadic pregnancy loss and recurrent miscarriage
AJ Devall, A Coomarasamy - Best Practice & Research Clinical Obstetrics & …, 2020 - Elsevier
Progesterone is essential for the maintenance of pregnancy, and progesterone deficiency is
associated with miscarriage. The subject of whether progesterone supplementation in early …
associated with miscarriage. The subject of whether progesterone supplementation in early …
Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis
G Griesinger, C Blockeel, E Kahler, C Pexman-Fieth… - PLoS …, 2020 - journals.plos.org
The aim of this systematic review and meta-analysis was to conduct a comprehensive
assessment of the evidence on the efficacy and safety of oral dydrogesterone versus …
assessment of the evidence on the efficacy and safety of oral dydrogesterone versus …
Sporadic miscarriage: evidence to provide effective care
A Coomarasamy, ID Gallos, A Papadopoulou… - The Lancet, 2021 - thelancet.com
The physical and psychological effect of miscarriage is commonly underappreciated. The
journey from diagnosis of miscarriage, through clinical management, to supportive aftercare …
journey from diagnosis of miscarriage, through clinical management, to supportive aftercare …
Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial
G Griesinger, C Blockeel, GT Sukhikh… - Human …, 2018 - academic.oup.com
STUDY QUESTION Is oral dydrogesterone 30 mg daily non-inferior to 8% micronized
vaginal progesterone (MVP) gel 90 mg daily for luteal phase support in IVF? SUMMARY …
vaginal progesterone (MVP) gel 90 mg daily for luteal phase support in IVF? SUMMARY …
Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction
G Griesinger, H Tournaye, N Macklon… - Reproductive …, 2019 - Elsevier
The pharmacological and physiological profiles of progestogens used for luteal phase
support during assisted reproductive technology are likely to be important in guiding clinical …
support during assisted reproductive technology are likely to be important in guiding clinical …
Micronized progesterone plus dydrogesterone versus micronized progesterone alone for luteal phase support in frozen-thawed cycles (MIDRONE): a prospective …
STUDY QUESTION Does the addition of oral dydrogesterone to vaginal progesterone as
luteal phase support improve pregnancy outcomes during frozen embryo transfer (FET) …
luteal phase support improve pregnancy outcomes during frozen embryo transfer (FET) …
[HTML][HTML] A critical appraisal of safety data on dydrogesterone for the support of early pregnancy: a scoping review and meta-analysis
A Katalinic, LP Shulman, JF Strauss… - Reproductive …, 2022 - Elsevier
No data support the suggestion that first-trimester dydrogesterone use increases the risk of
foetal abnormalities; however, two low-quality retrospective studies (one retracted by the …
foetal abnormalities; however, two low-quality retrospective studies (one retracted by the …
The pharmacodynamics and safety of progesterone
PCM Piette - Best Practice & Research Clinical Obstetrics & …, 2020 - Elsevier
Natural progesterone (P4) has a unique pharmacodynamic activity and safety profile
compared to the synthetic progestins. As a result, a class effect does not exist for both P4 …
compared to the synthetic progestins. As a result, a class effect does not exist for both P4 …
Progestogens and pregnancy loss
HJA Carp - Climacteric, 2018 - Taylor & Francis
Progestational agents are often prescribed to prevent pregnancy loss. Progestogens affect
implantation, cytokine balance, natural killer cell activity, arachidonic acid release and …
implantation, cytokine balance, natural killer cell activity, arachidonic acid release and …
Neonatal outcomes and congenital malformations in children born after dydrogesterone application in progestin-primed ovarian stimulation protocol for IVF: a …
J Huang, Q Xie, J Lin, X Lu, N Wang… - Drug Design …, 2019 - Taylor & Francis
Purpose Dydrogesterone (DYG) has been demonstrated to be an alternative progestin in the
progestin-primed ovarian stimulation (PPOS) protocol with comparable oocyte retrieval and …
progestin-primed ovarian stimulation (PPOS) protocol with comparable oocyte retrieval and …